-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Ironwood Pharmaceuticals Raises Full-Year 2026 Financial Guidance Driven by Continued LINZESS U.S. Net Sales Growth and Strong Third Quarter Financial Performance

Dow Jones·11/05/2026 12:05:00

Please log in to view news